8-K current report · filed Nov 6, 2026

aTYR PHARMA INC (ATYR) 8-K Current Report: November 6, 2026

Item 8.01ATYR overview

Short answer

aTYR PHARMA INC (ATYR) filed an 8-K current report with the SEC on November 6, 2026 reporting Item 8.01 (Other Events). ATM equity offering of up to $79,994,251 through Jefferies under the existing Sales Agreement.

aTYR PHARMA INC 8-K event analysis

AI summary of each reported item and its exhibits

Item 8.01 · Other Events

  • ATM equity offering of up to $79,994,251 through Jefferies under the existing Sales Agreement
  • Potential share issuance creates dilution risk for existing ATYR shareholders
  • Flexible at-the-market structure enables incremental funding rather than a single upfront financing
  • Proceeds likely strengthen liquidity for corporate and development activities, though use of proceeds is not specified here

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other aTYR PHARMA INC 8-K filings

Get the next ATYR 8-K as it lands

Follow ATYR for push alerts, or ask the research agent what this filing means.